Dangerous Doses: How Counterfeiters Are Contaminating America's Drug Supply

Science News, Sept 17, 2005

DANGEROUS DOSES: How Counterfeiters Are Contaminating America's Drug Supply

KATHERINE EBAN

Investigative reporter Eban began her research into counterfeit drugs for a 2003 article for Self magazine. After being shocked by the seedy side of the prescription drug trade, she did the extensive reporting that created this in-depth report. This is not a tale of brand-name narcotics ending up on the street, but just the opposite. Here, counterfeit, stolen, and otherwise-compromised products make their way to unsuspecting patients. Eban details back-alley sales of crates of counterfeit versions of Lipitor, Procrit, Epogen, and other drugs. These same bulk shipments end up in supposedly legitimate wholesalers' possession and then on pharmacy and hospital shelves, Eban writes. The account starts with a Miami-warehouse burglary and winds from there across the country, into pharmaceutical factories and to the chambers of Congress. The author introduces so many characters on both sides of the law that she includes an eight-page "who's who" directory. Lending gravity to Eban's muckraking style are dozens of pages of endnotes. Eban also provides an index and a glossary. The author concludes that the public can no longer trust the purity of drugs, even those supplied by reputable pharmacies. Harcourt, 2005, 320 p., b&w illus, hardcover, $25.00.

COPYRIGHT 2005 Science Service, Inc.
COPYRIGHT 2005 Gale Group
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
CXO UnpluggedSmart Business interviews on BNET

See and hear how senior level executives across the Asia Pacific are developing smart business ideas across a variety of sectors. The focus is on the future, and on how businesses need to evolve.

advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale